Edition:
United States

CombiMatrix Corp (CBMX.OQ)

CBMX.OQ on NASDAQ Stock Exchange Capital Market

7.35USD
17 Aug 2017
Change (% chg)

$-0.20 (-2.65%)
Prev Close
$7.55
Open
$7.45
Day's High
$7.45
Day's Low
$7.30
Volume
3,940
Avg. Vol
15,677
52-wk High
$7.90
52-wk Low
$2.15

CBMX.OQ

Chart for CBMX.OQ

About

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $21.89
Shares Outstanding(Mil.): 2.92
Dividend: --
Yield (%): --

Financials

  CBMX.OQ Industry Sector
P/E (TTM): -- 29.05 32.84
EPS (TTM): -0.91 -- --
ROI: -32.95 6.56 14.86
ROE: -33.95 10.42 16.11

BRIEF-Stonepine Capital Management reports 9.96 pct passive stake in Combimatrix as of Aug 2

* Stonepine Capital Management Llc reports 9.96 percent passive stake in Combimatrix Corp as of August 2, 2017 - sec filling Source text (http://bit.ly/2vFJEV0) Further company coverage:

Aug 09 2017

BRIEF-Combimatrix Corp reports Q2 loss per share $0.13

* Combimatrix Corp reports second quarter 2017 financial and operating results

Aug 03 2017

BRIEF-Combimatrix to be acquired for $33 mln in Invitae common stock

* Combimatrix enters into merger agreement with Invitae Corporation to be acquired for $33 million in Invitae common stock

Jul 31 2017

BRIEF-CombiMatrix Q1 loss per share $0.19

* CombiMatrix Corporation reports first quarter 2017 financial and operating results

May 04 2017

BRIEF-CombiMatrix Corporation Q4 loss per share $0.22

* CombiMatrix Corporation reports 2016 fourth quarter and full year financial and operating results

Feb 22 2017

Competitors

Earnings vs. Estimates